Have a personal or library account? Click to login
Association Between 4q25 Variants, Risk of Atrial Fibrillation and Echocardiographic Parameters Cover

Association Between 4q25 Variants, Risk of Atrial Fibrillation and Echocardiographic Parameters

Open Access
|Feb 2020

References

  1. Aguirre, L. A., Alonso, M. E., Badía-Careaga, C., Rollán, I., Arias, C., Fernández-Miñán, A., López-Jiménez, E., Aránega, A., Gómez-Skarmeta, J. L., Franco, D., Manzanares, M. (2015). Long-range regulatory interactions at the 4q25 atrial fibrillation risk locus involve PITX2c and ENPEP. BMC Biol., 13, 26.10.1186/s12915-015-0138-0441633925888893
  2. Benjamin Shoemaker, M., Muhammad, R., Parvez, B., White, B.W., Streur, M., Song, Y., Stubblefield, T., Kucera, G., Blair, M., Rytlewski, J., et al. (2013). Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation. Heart Rhythm,10, 394–400.10.1016/j.hrthm.2012.11.012358735723178686
  3. Bodineau, L., Frugičre, A., Marc, Y., Claperon, C., Llorens-Cortes, C. (2008). Aminopeptidase A inhibitors as centrally acting antihypertensive agents. Heart Failure Rev., 13, 311–319.10.1007/s10741-007-9077-318175217
  4. Campione, M., Steinbeisser, H., Schweickert, A., Deissler, K., van Bebber, F., Lowe, L. A., Nowotschin, S., Viebahn, C., Haffter, P., Kuehn, M. R., Blum, M. (1999). The homeobox gene Pitx2: Mediator of asymmetric left-right signaling in vertebrate heart and gut looping. Development,126, 1225–1234.10.1242/dev.126.6.122510021341
  5. Chen, F., Yang, Y., Zhang, R., Zhang, S., Dong, Y., Yin, X., Chang, D., Yang, Z., Wang, K., Gao, L., Xia, Y. (2016). Polymorphism rs2200733 at chromosome 4q25 is associated with atrial fibrillation recurrence after radiofrequency catheter ablation in the Chinese Han population. Amer. J. Transl. Res.,8, 688–697.
  6. Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstr, M, Benjamin, E. J., Gillum, R. F., Kim, Y. H., McAnulty, J. H., Zheng, Z. J., Forouzanfar, M. H., Naghavi, M., Mensah, G. A., Ezzati, M., Murray, C. J. (2014). Worldwide epidemiology of atrial fibrillation. Circulation, 129, 837–847.10.1161/CIRCULATIONAHA.113.005119415130224345399
  7. Cochet, H., Dubois, R., Yamashita, S., Al Jefairi, N., Berte, B., Sellal, J.-M., Hooks, D., Frontera, A., Amraoui, S., Zemoura, A., et al. (2018). Relationship between fibrosis detected on late gadolinium-enhanced cardiac magnetic resonance and re-entrant activity assessed with electrocardiographici in human persistent atrial fibrillation. JACC Clin. Electrophysiol.,4, 17–29.10.1016/j.jacep.2017.07.019582473129479568
  8. Ellinor, P. T., Lunetta, K. L., Albert, C. M., Glazer, N. L., Ritchie, M. D., Smith, A. V., Arking, D. E., Müller-Nurasyid, M., Krijthe, B. P., Lubitz, S. A., et al. (2012). Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat. Genet., 44, 670–675.10.1038/ng.2261336603822544366
  9. Feghal, J., Zakka, P., London, B., MacRae, C. A., Refaat, M. M. (2018). Genetics of atrial fibrillation. J. Amer. Heart Assoc., 7, e009884.10.1161/JAHA.118.009884647496030371258
  10. Ferrán, A., Alegret, J. M., Subirana, I., Aragončs, G., Lluis-Ganella, C., Romero-Menor, C., Planas, F., Joven, J., Elosua, R. (2014). Association between rs2200733 and rs7193343 genetic variants and atrial fibrillation in a Spanish population, and meta-analysis of previous studies. Rev. Esp. Cardiol. (Engl Ed)67, 822–829.10.1016/j.recesp.2013.12.021
  11. Gore-Panter, S. R., Hsu, J., Hanna, P., Gillinov, A. M., Pettersson, G., Newton, D. W., Moravec, C. S., Van Wagoner, D. R., Chung, M. K., Barnard, J., Smith, J. D. (2014). Atrial Fibrillation associated chromosome 4q25 variants are not associated with PITX2c expression in human adult left atrial appendages. PLoS ONE, 9, e86245.10.1371/journal.pone.0086245389922524465984
  12. Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., Jonasdottir, A., Baker, A., Thorleifsson, G., Kristjansson, K., et al. (2007). Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature,448, 353–357.10.1038/nature06007
  13. Husser, D., Adams, V., Piorkowski, C., Hindricks, G., Bollmann, A. (2010). Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J. Amer. Coll. Cardiol.,55, 747–753.10.1016/j.jacc.2009.11.041
  14. Iwasaki, Y., Nishida, K., Kato, T., Nattel, S. (2011). Atrial fibrillation pathophysiology: Implications for management. Circulation,124, 2264–2274.10.1161/CIRCULATIONAHA.111.019893
  15. Kahr, P. C., Piccini, I., Fabritz, L., Greber, B., Schöler, H., Scheld, H. H., Hoffmeier, A., Brown, N. A., Kirchhof, P. (2011). Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue. PLoS ONE, 6, e26389.10.1371/journal.pone.0026389
  16. Kathiriya, I. S., Srivastava, D. (2000). Left-right asymmetry and cardiac looping: implications for cardiac development and congenital heart disease. Amer. J. Med. Genet.,97, 271–279.10.1002/1096-8628(200024)97:4<271::AID-AJMG1277>3.0.CO;2-O
  17. Kiliszek, M., Franaszczyk, M., Kozluk, E., Lodzinski, P., Piatkowska, A., Broda, G., Ploski, R., Opolski, G. (2011). Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish population. PLoS ONE, 6, e21790.10.1371/journal.pone.0021790
  18. Kirchhof, P., Kahr, P. C., Kaese, S., Piccini, I., Vokshi, I., Scheld, H.-H., Rotering, H., Fortmueller, L., Laakmann, S., Verheule, S., Schotten, U., Fabritz, L., Brown, N. A. (2011). PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ. Cardiovasc. Genet.,4, 123–133.10.1161/CIRCGENETICS.110.958058
  19. Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. J. Cardiothorac. Surg.,50, e1–e88.10.1016/j.rec.2016.11.033
  20. Knackstedt, C., Gramley, F., Schimpf, T., Mischke, K., Zarse, M., Plisiene, J., Schmid, M., Lorenzen, J., Frechen, D., Neef, P., Hanrath, P., Kelm, M., Schauerte, P. (2008). Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. Cardiovascu. Pathol.,17, 318–324.10.1016/j.carpath.2007.12.003
  21. Lee, J., Jang, I. (2018). Predictors affecting postoperative atrial fibrillation in patients after coronary artery bypass graft. Clin. Nurs. Res., doi: 10.1177/1054773818809285.10.1177/1054773818809285
  22. Lee, K.-T., Yeh, H.-Y., Tung, C.-P., Chu, C.-S., Cheng, K.-H., Tsai, W.-C., Lu, Y.-H., Chang, J.-G., Sheu, S.-H., Lai, W.-T. (2010a). Association of RS2200733 but not RS10033464 on 4q25 with atrial fibrillation based on the recessive model in a Taiwanese population. Cardiology, 116, 151–156.10.1159/000318172
  23. Lee, Y.-S., Hyun, D. W., Jung, B. C., Cho, Y. K., Lee, S. H., Shin, D. G., Park, H. S., Han, S. W., Kim, Y. N. (2010b). Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter. J. Cardiol.,56, 348–353.10.1016/j.jjcc.2010.07.00620889311
  24. Lijnen, P. J., Petrov, V. V., Fagard, R. H. (2000). Induction of cardiac fibrosis by angiotensin II. Methods Find Exp. Clin. Pharmacol., 22, 709–723.10.1358/mf.2000.22.10.80228711346891
  25. Liu, L., Ebana, Y., Nitta, J.-I., Takahashi, Y., Miyazaki, S., Tanaka, T., Komura, M., Isobe, M., Furukawa, T. (2017). Genetic variants associated with susceptibility to atrial fibrillation in a Japanese population. Can. J. Cardiol.,33, 443–449.10.1016/j.cjca.2016.10.02928129963
  26. Lubitz, S. A., Lunetta, K. L., Lin, H., Arking, D. E., Trompet, S., Li, G., Krijthe, B. P., Chasman, D. I., Barnard, J., Kleber, M. E., et al. (2014). Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J. Amer. Coll. Cardiol., 63, 1200–1210.10.1016/j.jacc.2013.12.015400924024486271
  27. Mancio, J., Azevedo, D., Fragao-Marques, M., Falcao-Pires, I., Leite-Moreira, A., Lunet, N., Fontes-Carvalho, R., Bettencourt, N. (2018). Meta-analysis of relation of epicardial adipose tissue volume to left atrial dilation and to left ventricular hypertrophy and functions. Amer. J. Cardiol.,123, 523–531.10.1016/j.amjcard.2018.10.020
  28. Mints, Y., Yarmohammadi, H., Khurram, I. M., Hoyt, H., Hansford, R., Zimmerman, S. L., Steinberg, S. J., Judge, D. P., Tomaselli, G. F., Calkins, H., Zipunnikov, V., Nazarian, S. (2015). Association of common variations on chromosome 4q25 and left atrial volume in patients with atrial fibrillation. Clin. Med. Insights Cardiol.,9, 39–45.10.4137/CMC.S21712443147726005361
  29. Mizutani, S., Ishii, M., Hattori, A., Nomura, S., Numaguchi, Y., Tsujimoto, M., Kobayshi, H., Murohara, T., Wright, J. W. (2008). New insights into the importance of aminopeptidase A in hypertension. Heart Failure Rev.,13, 273–284.10.1007/s10741-007-9065-7710167417990103
  30. Mommersteeg, M. T. M., Brown, N. A., Prall, O. W. J., de Gier-de Vries, C., Harvey, R. P., Moorman, A. F. M., Christoffels, V. M. (2007). Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ. Res.101, 902–909.10.1161/CIRCRESAHA.107.16118217823370
  31. Morgan, R., Colman, M. A., Chubb, H., Seemann, G., Aslanidi, O. V. (2016). Slow conduction in the border zones of patchy fibrosis stabilizes the drivers for atrial fibrillation: Insights from multi-scale human atrial modeling. Front Physiol.,7, 474.10.3389/fphys.2016.00474507909727826248
  32. Morsy, M., Slomka, T., Shukla, A., Uppal, D., Bomb, R., Akinseye, O. A., Koshy, S. K. G., Garg, N. (2018). Clinical and echocardiographic predictors of new-onset atrial fibrillation in patients admitted with blunt trauma. Echocardiography, 35, 1519–1524.10.1111/echo.1409029981181
  33. Nielsen, J. B., Thorolfsdottir, R. B., Fritsche, L. G., Zhou, W., Skov, M. W., Graham, S. E., Herron, T. J., McCarthy, S., Schmidt, E. M., Sveinbjornsson, G., et al. (2018). Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat. Genet., 50, 1234–1239.10.1038/s41588-018-0171-3653077530061737
  34. Nistri, S., Galderisi, M., Ballo, P., Olivotto, I., D’Andrea, A., Pagliani, L., Santoro, A., Papesso, B., Innelli, P., Cecchi, F., Mondillo, S. (2011). Determinants of echocardiographic left atrial volume: Implications for normalcy. Eur. J. Echocardiogr.,12, 826–833.10.1093/ejechocard/jer137
  35. Olsen, F. J., Møgelvang, R., Jensen, G. B., Jensen, J. S., Biering-Sørensen, T. (2018). Relationship between left atrial functional measures and incident atrial fibrillation in the general population. JACC: Cardiovasc. Imaging,18, 14–17.
  36. O’Neal, W. T., Sandesara, P., Patel, N., Venkatesh, S., Samman-Tahhan, A., Hammadah, M., Kelli, H. M., Soliman, E. Z. (2017). Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction. Eur. Heart J. Cardiovasc. Imaging,18, 725–729.10.1093/ehjci/jex038
  37. O’Neill, J., Swoboda, P. P., Plein, S., Tayebjee, M. H. (2018). Left atrial size and function in a South Asian population and their potential influence on the risk of atrial fibrillation. Clin. Cardiol.,41, 1379–1385.10.1002/clc.23064
  38. Plawecki, M., Morena, M., Kuster, N., Chenine, L., Leray-Moragues, H., Jover, B., Fesler, P., Lotierzo, M., Dupuy, A.-M., Klouche, K., Cristol, J. P. (2018). sST2 as a new biomarker of chronic kidney disease-induced cardiac remodeling: Impact on risk prediction. Mediators Inflamm.,2018, 3952526.10.1155/2018/3952526
  39. Roselli, C., Chaffin, M. D., Weng, L.-C., Aeschbacher, S., Ahlberg, G., Albert, C. M., Almgren, P., Alonso, A., Anderson, C. D., Aragam, K. G., et al. (2018). Multi-ethnic genome-wide association study for atrial fibrillation. Nat. Genet., 50, 1225–1233.10.1038/s41588-018-0133-9
  40. Saha, M., Roney, C. H., Bayer, J. D., Meo, M., Cochet, H., Dubois, R., Vigmond, E. J. (2018). Wavelength and fibrosis affect phase singularity locations during atrial fibrillation. Front Physiol, 9, 1207.10.3389/fphys.2018.01207
  41. Sanfilippo, A. J., Abascal, V. M., Sheehan, M., Oertel, L. B., Harrigan, P., Hughes, R. A., Weyman, A. E. (1990). Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation, 82, 792–797.10.1161/01.CIR.82.3.792
  42. Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D., Newton-Cheh, C., Lubitz, S. A., Magnani, J. W., Ellinor, P. T., Seshadri, S., Wolf, P. A., Vasan, R. S., Benjamin, E. J., Levy, D. (2015). 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. Lancet,386, 154–162.10.1016/S0140-6736(14)61774-8
  43. Shin, S.-H., Park, M.-Y., Oh, W.-J., Hong, S.-J., Pak, H.-N., Song, W.-H., Lim, D.-S., Kim, Y.-H., Shim, W.-J. (2008). Left atrial volume is a predictor of atrial fibrillation recurrence after catheter ablation. J. Amer. Soc. Echocardiogr.,21, 697–702.10.1016/j.echo.2007.10.02218187293
  44. Shoemaker, M. B., Bollmann, A., Lubitz, S. A., Ueberham, L., Saini, H., Montgomery, J., Edwards, T., Yoneda, Z., Sinner, M. F., Arya, A., et al. (2015). Common genetic variants and response to atrial fibrillation ablation. Circ. Arrhythm. Electrophysiol.,8, 296–302.10.1161/CIRCEP.114.001909473187125684755
  45. Tanabe, K., Yamaguchi, K., Tani, T., Yagi, T., Katayama, M., Tamita, K., Kinoshita, M., Kaji, S., Yamamuro, A., Morioka, Sokada, Y., Kihara, Y. (2007). Left atrial volume: Predictor of atrial fibrillation in patients with degenerative mitral regurgitation. J. Heart Valve Dis.,16, 8–12.
  46. Tao, Y., Zhang, M., Li, L., Bai, Y., Zhou, Y., Moon, A. M., Kaminski, H. J., Martin, J. F. (2014). Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes. Circ. Cardiovasc. Genet.,7, 23–32.10.1161/CIRCGENETICS.113.000259401350024395921
  47. Voskoboinik, A., Costello, B. T., Kalman, E., Prabhu, S., Sugumar, H., Wong, G., Nalliah, C., Ling, L.-H., McLellan, A., Hettige, T., Springer, F., La Gerche, A., Kalman, J. M., Taylor, A. J., Kistler, P. M. (2018). Regular alcohol consumption is associated with impaired atrial mechanical function in the atrial fibrillation population: A cross-sectional MRI-based study. JACC Clin. Electrophysiol.,4, 1451–1459.10.1016/j.jacep.2018.07.01030466852
  48. Wang, J., Klysik, E., Sood, S., Johnson, R. L., Wehrens, X. H. T., Martin, J. F. (2010). Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc. Natl. Acad. Sci. U.S.A., 107, 9753–9758.10.1073/pnas.0912585107290683820457925
  49. Ye, J., Tucker, N. R., Weng, L.-C., Clauss, S., Lubitz, S. A., Ellinor, P. T. (2016). A functional variant associated with atrial fibrillation regulates PITX2c expression through TFAP2a. Amer. J. Hum. Genet.,99, 1281–1291.10.1016/j.ajhg.2016.10.001514210627866707
  50. Zoni-Berisso, M., Lercari, F., Carazza, T., Domenicucci, S. (2014). Epidemiology of atrial fibrillation: European perspective. Clin. Epidemiol.,6, 213–220.10.2147/CLEP.S47385406495224966695
DOI: https://doi.org/10.2478/prolas-2020-0001 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 1 - 6
Submitted on: Jan 11, 2019
|
Accepted on: Oct 16, 2019
|
Published on: Feb 27, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:

© 2020 Irina Rudaka, Dmitrijs Rots, Arturs Uzars, Oskars Kalējs, Linda Gailīte, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.